Deprenyl is a selective inhibitor of brain MAO-B in the long-term treatment of Parkinsons's disease.
D000368:Aged; D001923:Brain Chemistry / Q000187:drug effects; D004298:Dopamine / Q000378:metabolism; D006801:Humans; D007980:Levodopa / Q000627:therapeutic use; D008297:Male; D008996:Monoamine Oxidase Inhibitors; D010084:Oxidation-Reduction; D010300:Parkinson Disease / Q000188:drug therapy / Q000201:enzymology*; D010627:Phenethylamines / Q000494:pharmacology*; D012642:Selegiline / Q000494:pharmacology* / Q000627:therapeutic use; D012701:Serotonin / Q000378:metabolism
D008996:Monoamine Oxidase Inhibitors; D010627:Phenethylamines; D012642:Selegiline; D012701:Serotonin; D007980:Levodopa; D004298:Dopamine